🇺🇸 DHA (Docosahexaenoic Acid) in United States

38 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 6 reports (15.79%)
  2. Dyspnoea — 5 reports (13.16%)
  3. Fatigue — 5 reports (13.16%)
  4. Gastrooesophageal Reflux Disease — 4 reports (10.53%)
  5. Arthralgia — 3 reports (7.89%)
  6. Condition Aggravated — 3 reports (7.89%)
  7. Covid-19 — 3 reports (7.89%)
  8. Death — 3 reports (7.89%)
  9. Diarrhoea — 3 reports (7.89%)
  10. Intentional Product Use Issue — 3 reports (7.89%)

Source database →

Other Neurology approved in United States

Frequently asked questions

Is DHA (Docosahexaenoic Acid) approved in United States?

DHA (Docosahexaenoic Acid) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for DHA (Docosahexaenoic Acid) in United States?

Alzheimer's Disease Cooperative Study (ADCS) is the originator. The local marketing authorisation holder may differ — check the official source linked above.